U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
EPCORITAMAB
D6OMY2L0WA
US Approved Rx (2023)
First approved in 2023
General
Names
7
Classification
1
Identifiers
7
Subunits
4
Related Substances
1
EPCORITAMAB
D6OMY2L0WA
US Approved Rx (2023)
First approved in 2023
General
Approval Year
2023
446
Names
7
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
EPCORITAMAB
Official Name
English
Immunoglobulin G1 [234-phenylalanine, 235-glutamic acid, 265-alanine, 405-leucine], anti-(human CD3 antigen) (human-Mus musculus monoclonal IgG1-huCACAO-FEAL ?1-chain), disulfide with human-Mus musculus monoclonal IgG1-huCACAO-FEAL ?-chain, (234?231'),(2
Preferred Name
English
epcoritamab [INN]
Common Name
English
EPCORITAMAB [USAN]
Common Name
English
Epcoritamab [WHO-DD]
Common Name
English
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of Follicular Lymphoma
FDA ORPHAN DRUG
865921
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
7
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
DAILYMED
D6OMY2L0WA
PRIMARY
CAS
2134641-34-0
PRIMARY
SMS_ID
300000010789
PRIMARY
INN
11078
PRIMARY
USAN
KL-92
PRIMARY
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
D6OMY2L0WA
EPCORITAMAB
